Skip to main content

Chronic TVP-1012 (rasagiline) dose — activity response of monoamine oxidases A and B in the brain of the common marmoset

  • Conference paper
MAO — The Mother of all Amine Oxidases

Summary

The stereospecific form of the known acetylenic mechanismbased MAO-inhibitor AGN1135 (Rasagiline, TVP-1012) is devoid of sympathomimetic amphetamine-like properties.

To evaluate the efficiency and selectivity of subcutaneous injections of TVP-1012 (dose range from 0.01 up to 10mg/kg for 7 days) the activities of monoamine oxidases A and B (MAO-A,-B) were determined in different brain regions of the common marmoset.

At a dose of 0.1mg/kg TVP-1012, almost 80% of MAO-B activity is inhibited in all brain regions investigated (prefrontal and occipital cortex, cerebellum, caudate nucleus, putamen, nucleus accumbens). In contrast, MAO-A is not inhibited in putamen and nucleus accumbens. However, by increasing the TVP-1012 dose to 0.5mg/kg, MAO-A is inhibited to a significant extent as well, concomitant to total inhibition of MAO-B.

The results obtained indicate that TVP-1012 irreversibly inhibits both types of MAO in the common marmoset with selectivity for MAO-B at doses less than 0.5mg/kg. TVP-1012 could be useful in studies requiring selective MAO-B inhibition without concomitant sympathomimetic amphetamine-like effects and could thus be of therapeutic interest for Parkinson’s disease and retarded depression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arnett CD, Fowler JS, MacGregor RR, Schlyer DJ, Wolf AP, Langström B, Halldin C (1987) Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl. J Neurochem 49: 522–527

    Article  PubMed  CAS  Google Scholar 

  • Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254

    Article  PubMed  CAS  Google Scholar 

  • Denney RM, Patel NT, Fritz RR, Abell CW (1982) A monoclonal antibody elicited to human platelet monoamine oxidase. Isolation and specificity for human monoamine oxidase B but not A. Mol Pharmacol 22: 500–508

    PubMed  CAS  Google Scholar 

  • Ekstedt B, Magyar K Knoll J (1978) Does the B form selective monoamine oxidase inhibitor deprenyl lose selectivity by long term treatment? Biochem Pharmacol 28: 919–923

    Article  Google Scholar 

  • Finberg JP, Tenne M, Youdim MBH (1981) Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B. Br J Pharmacol 73: 65–74

    Article  PubMed  CAS  Google Scholar 

  • Finberg JPM, Youdim MBH, Levy R, Sterling S, Eliash S (1991a) Pharmacology of TVP 1012, a selective inhibitor of MAO type B lacking sympathomimetic action. In: Proceedings of the Tenth International Symposium on Parkinson’s Disease. University Press, Tokyo, p 108

    Google Scholar 

  • Finberg JPM, Youdim MBH, Levy R, Sterling S, Eliash S (1991b) TVP 1012, a potent and selective irreversible inhibitor of MAO type B. In: Proceedings of the Tenth International Symposium on Parkinson’s Disease. University Press, Tokyo, p 134

    Google Scholar 

  • Finberg JPM, Lamensdorf I, Commissiong JW, Youdim MBH (1996) Pharmacology and neuroprotective properties of rasagiline. J Neural Transm [Suppl 48]: 95–103

    Google Scholar 

  • Gerlach M, Riederer P, Youdim MBH (1992) The molecular pharmacology of L-deprenyl. Eur J Pharmacol Mol Pharmacol Sect 226: 97–108

    Article  CAS  Google Scholar 

  • Huether G, Reimer A, Schmidt F, Schuff-Werner P, Brudny MM (1990) Oxidation of the indole nucleus of 5-hydroxytryptamine and formation of dimers in the presence of peroxidase and H2O2. J Neural Transm [Suppl] 32: 249–257

    CAS  Google Scholar 

  • Kalir A, Sabbagh A, Youdim MBH (1981) Selective acetylenic “suicide” and reversible inhibitors of monoamine oxidase types A and B. Br J Pharmacol 73: 55–64

    Article  PubMed  CAS  Google Scholar 

  • Knoll J, Ecsery Z, Magyar K, Satory E (1978) Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action. Biochem Pharmacol 27: 1739–1747

    Article  PubMed  CAS  Google Scholar 

  • Konradi C, Svoma E, Jellinger K, Riederer P, Denney R, Thibault J (1988) Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem. Neuroscience 26: 791–802

    Article  PubMed  CAS  Google Scholar 

  • Konradi C, Kornhuber J, Frölich L, Fritze J, Heinsen H, Beckmann H, Schulz E, Riederer P (1989) Demonstration of monamine oxidase-A and-B in the human brainstem by a histochemical technique. Neuroscience 33: 383–400

    Article  PubMed  CAS  Google Scholar 

  • Krueger MJ, Singer TP (1993) An examination of the reliability of the radiochemical assay for monoamine oxidases A and B. Anal Biochem 214: 116–123

    Article  PubMed  CAS  Google Scholar 

  • Maitre L, Delini-Stula A, Waldmeier PC (1976) Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats. In: Wolstenholme GEW, Knight J (eds) Monoamine oxidase and its inhibition. Elsevier, Amsterdam, pp 247–267 (Ciba Fdn Symp)

    Google Scholar 

  • Riederer P, Youdim MBH (1986) Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with L-deprenyl. J Neurochem 46: 1359–1365

    Article  PubMed  CAS  Google Scholar 

  • Saura J, Kettler R, Da Prada M, Richards JG (1992) Quantitative enzyme radioautogra-phy with 3H-Ro 41-1049 and 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs and human brain. J Neurosci 12: 1977–1999

    PubMed  CAS  Google Scholar 

  • Shih JC, Grimsby J, Chen K (1990) The expression of human MAO-A and B genes. J Neural Transm [Suppl] 32: 41–47

    CAS  Google Scholar 

  • Stenström A, Hardy J, Oreland L (1987) Intra-and extra-DA-synaptosomal localization of monoamine oxidase in striatal homogenates from four species. Biochem Pharmacol 18: 2931–2935

    Article  Google Scholar 

  • Stephan H, Baron G, Schwerdtfeger WK (1980) The brain of the common marmoset (Callithrix jacchus)-a stereotaxic atlas. Springer, Berlin Heidelberg New York

    Book  Google Scholar 

  • Tipton KF, Youdim MBH (1976) Assay of monoamine oxidase. In: Wolstenholme GEW, Knight J (eds) Monoamine oxidase and its inhibition. Excerpta Medica, North-Holland, pp 393–403

    Google Scholar 

  • Tipton KF, Youdim MBH (1983) The assay of monoamine oxidase. In: Parvez S, Nagatsu T, Nagatsu I, Parvez H (eds) Methods in biogenic amine research. Elsevier, Amsterdam, pp 441–465

    Google Scholar 

  • Tipton KF, Singer TP (1993) The biochemical assay for monoamine oxidase activity. Problems and pitfalls. Biochem Pharmacol 46: 1311–1316

    Article  PubMed  CAS  Google Scholar 

  • Ueki A, Willoughby J, Glover V, Sandler M (1989) Distribution of phenolsulfo-transferase and monoamine oxidase in the common marmoset. Biochem Pharmacol 38: 2383–2385

    Article  PubMed  CAS  Google Scholar 

  • Westlund KN, Denney RM, Rose RM, Abell CW (1988) Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem. Neurosci 25: 439–456

    Article  CAS  Google Scholar 

  • Wurtman RJ, Axelrod J (1963) A sensitive and specific assay for the estimation of monoamine oxidase. Biochem Pharmacol 12: 1439–1441

    Article  PubMed  CAS  Google Scholar 

  • Youdim MBH, Finberg JPM (1987) MAO type B inhibitors as adjunct to L-DOPA therapy. Adv Neurol 45: 127–136

    PubMed  CAS  Google Scholar 

  • Youdim MBH, Finberg JPM, Tipton KF (1988) Monoamine oxidase. In: Trendelenburg U, Weiner N (eds) Handbook of experimental pharmacology, vol 90/1. Springer, Berlin Heidelberg New York Tokyo, pp 119–192

    Google Scholar 

  • Yoles E, Schwartz M (1995) N-Propargyl-1 (R)-Aminoindan (TVP-1012), a putative neuroprotective agent, enhances in vitro neuronal survival after glutamate toxicity. Soc Neurosci Abstr 230.18: 562

    Google Scholar 

  • Yu PH (1986) Monoamine oxidase. In: Boulton AA, Baker GB, Yu PH (eds) Neuromethods, vol 5. Humana Press, Clifton, pp 235–272

    Google Scholar 

  • Zhu Q-S, Grimsby J, Chen K, Shih JC (1992) Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J Neurosci 12: 4437–4446

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Wien

About this paper

Cite this paper

Götz, M.E. et al. (1998). Chronic TVP-1012 (rasagiline) dose — activity response of monoamine oxidases A and B in the brain of the common marmoset. In: Finberg, J.P.M., Youdim, M.B.H., Riederer, P., Tipton, K.F. (eds) MAO — The Mother of all Amine Oxidases. Journal of Neural Transmission. Supplement, vol 52. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6499-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6499-0_27

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83037-6

  • Online ISBN: 978-3-7091-6499-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics